标题
Screening for MAFLD: who, when and how?
作者
关键词
-
出版物
Therapeutic Advances in Endocrinology and Metabolism
Volume 14, Issue -, Pages 204201882211456
出版商
SAGE Publications
发表日期
2023-01-21
DOI
10.1177/20420188221145650
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Global Prevalence and Clinical Characteristics of Metabolic Associated Fatty Liver Disease. A Meta-Analysis and Systematic Review of 10,739,607 Individuals
- (2022) Kai En Chan et al. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM
- Metabolic dysfunction-associated fatty liver disease (MAFLD) and non-alcoholic fatty liver disease (NAFLD): distinct fatty liver entities with different clinical outcomes?
- (2022) Eda Kaya et al. Hepatobiliary Surgery and Nutrition
- Global multi-stakeholder endorsement of the MAFLD definition
- (2022) Nahum Méndez-Sánchez et al. Lancet Gastroenterology & Hepatology
- Detangling the interrelations between MAFLD, insulin resistance, and key hormones
- (2022) Shreya C. Pal et al. Hormones-International Journal of Endocrinology and Metabolism
- Metabolic (dysfunction)-associated fatty liver disease in individuals of normal weight
- (2022) Mohammed Eslam et al. Nature Reviews Gastroenterology & Hepatology
- Validation of conventional non-invasive fibrosis scoring systems in patients with metabolic associated fatty liver disease
- (2021) Yin-Lian Wu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Differential Clinical Characteristics and Mortality Outcomes in Persons With NAFLD and/or MAFLD
- (2021) Vy H. Nguyen et al. Clinical Gastroenterology and Hepatology
- Biomarkers of Metabolic (Dysfunction)-associated Fatty Liver Disease: An Update
- (2021) Jawaher Alharthi et al. Journal of Clinical and Translational Hepatology
- Exposure to air pollution is associated with an increased risk of metabolic dysfunction-associated fatty liver disease
- (2021) Bing Guo et al. JOURNAL OF HEPATOLOGY
- Among simple non-invasive scores, Pro-C3 and ADAPT best exclude advanced fibrosis in Asian patients with MAFLD
- (2021) Liang-Jie Tang et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- The effects of resveratrol on lipid profiles and liver enzymes in patients with metabolic syndrome and related disorders: a systematic review and meta-analysis of randomized controlled trials
- (2020) Maryam Akbari et al. Lipids in Health and Disease
- Epidemiology and pathophysiology of the association between NAFLD and metabolically healthy or metabolically unhealthy obesity
- (2020) Amedeo Lonardo et al. Annals of Hepatology
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
- (2020) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- Global prevalence, incidence, and outcomes of non-obese or lean non-alcoholic fatty liver disease: a systematic review and meta-analysis
- (2020) Qing Ye et al. Lancet Gastroenterology & Hepatology
- Non-alcoholic fatty liver disease in non-obese individuals: the impact of metabolic health
- (2020) Mohammed Eslam et al. Lancet Gastroenterology & Hepatology
- Clinical assessment for high-risk patients with non-alcoholic fatty liver disease in primary care and diabetology practices
- (2020) Zobair M. Younossi et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- Concordance of MAFLD and NAFLD diagnostic criteria in “real‐world” data
- (2020) Giovanni Targher LIVER INTERNATIONAL
- Biomarkers of liver fibrosis: prospective comparison of multimodal magnetic resonance, serum algorithms and transient elastography
- (2020) Mikael F. Forsgren et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Effects of Resveratrol Supplementation in Patients with Non-Alcoholic Fatty Liver Disease—A Meta-Analysis
- (2020) Karolina Jakubczyk et al. Nutrients
- Accuracy of Fibrosis-4 index and non-alcoholic fatty liver disease fibrosis scores in metabolic (dysfunction) associated fatty liver disease according to body mass index
- (2020) Fatih Eren et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
- (2020) Mohammed Eslam et al. Hepatology International
- Effects of resveratrol supplementation on liver enzymes: A systematic review and meta‐analysis of randomised controlled trials
- (2020) Mina Darand et al. INTERNATIONAL JOURNAL OF CLINICAL PRACTICE
- A Sequential Algorithm Combining ADAPT and Liver Stiffness Can Stage Metabolic-Associated Fatty Liver Disease in Hospital-Based and Primary Care Patients
- (2020) Mohammed Eslam et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- A single-letter change in an acronym: signals, reasons, promises, challenges, and steps ahead for moving from NAFLD to MAFLD
- (2020) Yusuf Yilmaz et al. Expert Review of Gastroenterology & Hepatology
- The Latin American Association for the Study of the Liver (ALEH) position statement on the redefinition of fatty liver disease
- (2020) Nahum Mendez-Sanchez et al. Lancet Gastroenterology & Hepatology
- Efficacy of resveratrol supplementation on liver enzymes in patients with non-alcoholic fatty liver disease: A systematic review and meta-analysis
- (2020) Shumin Wei et al. COMPLEMENTARY THERAPIES IN MEDICINE
- Diagnosis of non-alcoholic fatty liver disease (NAFLD): current concepts.
- (2019) Margarita Papatheodoridi et al. CURRENT PHARMACEUTICAL DESIGN
- Implications of the introduction of new criteria for the diagnosis of gestational diabetes: a health outcome and cost of care analysis
- (2019) Thomas J Cade et al. BMJ Open
- Lean NAFLD : A Distinct Entity Shaped by Differential Metabolic Adaptation
- (2019) Fei Chen et al. HEPATOLOGY
- The management of incidental fatty liver found on imaging. What do we need to do?
- (2018) Nahum Méndez-Sánchez et al. AMERICAN JOURNAL OF GASTROENTEROLOGY
- More Evidence for the Genetic Susceptibility of Mexicans Population to Nonalcoholic Fatty Liver Disease through PNPLA3
- (2018) Paulina Chinchilla-López et al. Annals of Hepatology
- Lifestyle interventions for patients with nonalcoholic fatty liver disease
- (2018) Tian-Tian Zou et al. EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY
- Fibrosis Severity as a Determinant of Cause-Specific Mortality in Patients With Advanced Nonalcoholic Fatty Liver Disease
- (2018) Eduardo Vilar-Gomez et al. GASTROENTEROLOGY
- ADAPT: An algorithm incorporating PRO-C3 accurately identifies patients with NAFLD and advanced fibrosis
- (2018) Samuel J. Daniels et al. HEPATOLOGY
- Serum Osteocalcin Levels in Children With Nonalcoholic Fatty Liver Disease
- (2018) Saleh Amin et al. JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION
- Nonalcoholic Fatty Liver Disease
- (2018) Xiao Jing Wang et al. ANNALS OF INTERNAL MEDICINE
- The diagnosis and management of nonalcoholic fatty liver disease: Practice guidance from the American Association for the Study of Liver Diseases
- (2017) Naga Chalasani et al. HEPATOLOGY
- Systematic Review and Meta-Analysis Resveratrol supplementation in patients with non-alcoholic fatty liver disease: systematic review and meta-analysis
- (2017) Journal of Gastrointestinal and Liver Diseases
- Global epidemiology of nonalcoholic fatty liver disease-Meta-analytic assessment of prevalence, incidence, and outcomes
- (2016) Zobair M. Younossi et al. HEPATOLOGY
- EASL–EASD–EASO Clinical Practice Guidelines for the management of non-alcoholic fatty liver disease
- (2016) JOURNAL OF HEPATOLOGY
- Clinical guidelines of non-alcoholic fatty liver disease: A systematic review
- (2016) Jin-Zhou Zhu et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Biomarkers in Nonalcoholic Fatty Liver Disease
- (2016) Manuela G Neuman et al. Canadian Journal of Gastroenterology and Hepatology
- Accuracy of MR Imaging–estimated Proton Density Fat Fraction for Classification of Dichotomized Histologic Steatosis Grades in Nonalcoholic Fatty Liver Disease
- (2015) An Tang et al. RADIOLOGY
- SIRT1 as a potential therapeutic target for treatment of nonalcoholic fatty liver disease
- (2013) Yasar Colak et al. MEDICAL SCIENCE MONITOR
- Chronic overexpression of PNPLA3I148M in mouse liver causes hepatic steatosis
- (2012) John Zhong Li et al. JOURNAL OF CLINICAL INVESTIGATION
- Controlled Attenuation Parameter (CAP): a noninvasive method for the detection of hepatic steatosis based on transient elastography
- (2012) Robert P. Myers et al. LIVER INTERNATIONAL
- Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease
- (2011) Silvia Sookoian et al. HEPATOLOGY
- SIRT1 Deacetylates and Inhibits SREBP-1C Activity in Regulation of Hepatic Lipid Metabolism
- (2010) Bhaskar Ponugoti et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Comparison of Noninvasive Markers of Fibrosis in Patients With Nonalcoholic Fatty Liver Disease
- (2009) Amy G. Shah et al. Clinical Gastroenterology and Hepatology
- Non-Alcoholic Fatty Liver Disease in Older People
- (2009) James Frith et al. GERONTOLOGY
- Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease
- (2008) Stefano Romeo et al. NATURE GENETICS
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now